financetom
Business
financetom
/
Business
/
--Street Color: Intel Delays Ohio Chip Production Facility Plan Til 2031: The Columbus Dispatch
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Street Color: Intel Delays Ohio Chip Production Facility Plan Til 2031: The Columbus Dispatch
Feb 28, 2025 7:44 AM

10:23 AM EST, 02/28/2025 (MT Newswires) --

Price: 24.21, Change: +1.12, Percent Change: +4.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Martin Marietta Materials' Q2 Earnings, Revenue Decline; Lowers FY Guidance
Martin Marietta Materials' Q2 Earnings, Revenue Decline; Lowers FY Guidance
Aug 8, 2024
07:27 AM EDT, 08/08/2024 (MT Newswires) -- Martin Marietta Materials ( MLM ) reported Q2 earnings from continuing operations Thursday of $4.76 per diluted share, down from $5.60 a year earlier. Analysts polled by Capital IQ expected $5.37. Revenue for the quarter ended June 30 was $1.76 billion compared with $1.82 billion a year earlier. Analysts polled by Capital IQ...
--Google, Meta Made Secret Deal to Target Teenagers With Ads, Financial Times Reports
--Google, Meta Made Secret Deal to Target Teenagers With Ads, Financial Times Reports
Aug 8, 2024
07:23 AM EDT, 08/08/2024 (MT Newswires) -- Price: 161.13, Change: +0.38, Percent Change: +0.24 ...
Analysis-Investors expect market selloff will slow, stretch and spread
Analysis-Investors expect market selloff will slow, stretch and spread
Aug 8, 2024
NEW YORK/SINGAPORE (Reuters) - This week's huge selloff in global markets, triggered by an unwinding of yen-funded trades, is far from over and could eventually spread to credit markets, impair some banks and possibly hurt the U.S. dollar, fund managers say. By Thursday, market volatility had subsided but stock markets struggled for direction and investors tried to guess how many...
Merck Halts Phase 3 Trial of Lung Cancer Combination Therapy
Merck Halts Phase 3 Trial of Lung Cancer Combination Therapy
Aug 8, 2024
07:23 AM EDT, 08/08/2024 (MT Newswires) -- Merck ( MRK ) said Thursday that it halted the phase 3 trial of its experimental combination therapy to treat patients with extensive-stage small cell lung cancer based on the recommendation of an independent data monitoring committee. The company said the trial, which tested a fixed-dose combination of vibostolimab and its blockbuster cancer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved